Breviscapine infusion preparation and its preparing method

A technology of breviscapine and preparations, which is applied in the field of medicine, can solve the problems of scutellarin, such as poor effect, poor stability, poor clarity, and easy pollution, so as to prevent cross-infection, ensure drug safety, and increase solubility.
CN1425385AInactive Publication Date: 2003-06-25上海博泰医药科技有限公司
0 Cites 47 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
上海博泰医药科技有限公司
Publication Date
2003-06-25
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

The Breviscapine infusion preparation is compounded with Breviscapine as main component, glucose or sodium chloride, propylene glycol, L-arginine, sodium bisulphate, EDTA-2Na and water for injection through certain technological process. The preparation is suitable for great dosage application clinically to avoid cross infection caused by intermediate links. In addition, the present invention is clear and stable.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the technical field of medicine, and specifically relates to an intravenous infusion preparation with breviscapine as the main component and a preparation method thereof, specifically breviscapine glucose injection and breviscapine sodium chloride injection and a preparation method thereof. Background technique

[0002] Breviscapus is a total flavonoid extracted from the plant Erigron breviscapus (Vaniot) Hand Mazz of Compositae, mainly used in the treatment of cardiovascular and cerebrovascular diseases. At present, it is widely used in clinical practice with definite curative effect, and the total effective rate is more than 90% for coronary heart disease, angina pectoris, cerebral thrombosis, paralysis caused by cerebral infarction and other diseases. The clinical application of breviscapine is mainly small injections. Clinical application has proved that the effect of small doses of breviscapine is not good, and only large ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More